Annals of Laboratory Medicine

Korean Society for Laboratory Medicine (대한진단검사의학회)
권호 표지
DOI QR코드

DOI QR Code

Aminoglycoside Susceptibility Profiles of Enterobacter cloacae Isolates Harboring the aac(6')-Ib Gene

  • Kim, Soo-Young (Department of Laboratory Medicine, College of Medicine, The Catholic University of Korea, St. Vincent’s Hospital) ;
  • Park, Yeon-Joon (Department of Laboratory Medicine, College of Medicine, The Catholic University of Korea, Seoul St. Mary’s Hospital) ;
  • Yu, Jin-Kyung (Department of Laboratory Medicine, College of Medicine, The Catholic University of Korea, Seoul St. Mary’s Hospital) ;
  • Kim, Yeong-Sic (Department of Laboratory Medicine, College of Medicine, The Catholic University of Korea, St. Vincent’s Hospital)
  • Published : 2011.10.30
⟨ Previous Next ⟩

Abstract

The aminoglycoside 6'-N-acetyltransferases of type Ib (aac(6')-Ib) gene confers resistance to amikacin, tobramycin, kanamycin, and netilmicin but not gentamicin. However, some isolates harboring this gene show reduced susceptibility to amikacin. The European Committee on Antimicrobial Susceptibility Testing (EUCAST) recommends a revision of the phenotypic description for isolates harboring the aac(6')-Ib gene. In this study, we determined the aminoglycoside susceptibility profiles of 58 AAC(6')-Ib-producing Enterobacter cloacae isolates. On the basis of the CLSI and EUCAST breakpoints, a large proportion (84.5% and 55.2%, respectively) of these 58 isolates were found to be susceptible to amikacin. However, among the isolates that were shown to be anikacin-susceptible according to the CLSI and EUCAST breakpoints, only 30.6% and 18.8% isolates, respectively, could be considered to have intermediate resistance on the basis of the EUCAST expert rules. Further studies should be conducted to determine the aminoglycoside susceptibility profiles of aac(6')-Ib-harboring isolates from various geographic regions and to monitor the therapeutic efficacy of amikacin in infections caused by these isolates.

Keywords

References

  1. Neonakis I, Gikas A, Scoulica E, Manios A, Georgiladakis A, Tselentis Y. Evolution of aminoglycoside resistance phenotypes of four gram-negative bacteria: an 8-year survey in a university hospital in Greece. Int J Antimicrob Agents 2003;22:526-31. https://doi.org/10.1016/S0924-8579(03)00152-3
  2. Kim JY, Park YJ, Kwon HJ, Han K, Kang MW, Woo GJ. Occurrence and mechanisms of amikacin resistance and its association with $\beta$-lactamases in Pseudomonas aeruginosa: a Korean nationwide study. J Antimicrob Chemother 2008;62:479-83. https://doi.org/10.1093/jac/dkn244
  3. Sabtcheva S, Kaku M, Saga T, Ishii Y, Kantardjjev T. High prevalence of the aac(6')-Ib-cr gene and its dissemination among Enterobacteriaceae isolates by CTX-M-15 plasmids in Bulgaria. Antimicrob Agents Chemother 2009;53:335-6. https://doi.org/10.1128/AAC.00584-08
  4. Kim SY, Park YJ, Yu JK, Kim YS, Han K. Prevalence and characteristics of aac(6')-Ib-cr in AmpC-producing Enterobacter cloacae, Citrobacter freundii, and Serratia marcescens: a multicenter study from Korea. Diagn Microbiol Infect Dis 2009;63:314-8. https://doi.org/10.1016/j.diagmicrobio.2008.11.016
  5. Casin I, Bordon F, Bertin P, Coutrot A, Podglajen I, Brasseur R, et al. Aminoglycoside 6'-N-acetyltransferase variants of the Ib type with altered substrate profile in clinical isolates of Enterobacter cloacae and Citrobacter freundii. Antimicrob Agents Chemother 1998; 42:209-15.
  6. Rather PN, Munayyer H, Mann PA, Hare RS, Miller GH, Shaw KJ. Genetic analysis of bacterial acetyltransferases: identification of amino acids determining the specificities of the aminoglycoside 6'-N-acetyltransferase Ib and IIa proteins. J Bacteriol 1992;174: 3196-203. https://doi.org/10.1128/jb.174.10.3196-3203.1992
  7. Shmara A, Weinsetel N, Dery KJ, Chavideh R, Tolmasky ME. Systematic analysis of a conserved region of the aminoglycoside 6'-N-acetyltransferase type Ib. Antimicrob Agents Chemother 2001;45: 3287-92. https://doi.org/10.1128/AAC.45.12.3287-3292.2001
  8. Park CH, Robicsek A, Jacoby GA, Sahm D, Hooper DC. Prevalence in the United States of aac(6')-Ib-cr encoding a ciprofloxacin-modifying enzyme. Antimicrob Agents Chemother 2006;50:3953-5. https://doi.org/10.1128/AAC.00915-06
  9. Clinical and Laboratory Standards Institute (CLSI). Performance standards for antimicrobial susceptibility testing; Nineteenth informational supplement, M100-S19. Wayne, PA: Clinical and Laboratory Standards Institute, 2009.
  10. Tenover FC, Arbeit RD, Goering RV, Mickelsen PA, Murray BE, Persing DH, et al. Interpreting chromosomal DNA restriction patterns produced by pulsed-field gel electrophoresis: criteria for bacterial strain typing. J Clin Microbiol 1995;33:2233-9.
  11. Caulin E, Coutrot A, Carbon C, Collatz E. Resistance to amikacin and isepamicin in rabbits with experimental endocarditis of an aac(6')-Ib-bearing strain of Klebsiella pneumoniae susceptible in vitro. Antimicrob Agents Chemother 1996;40:2848-53.

Cited by

  1. Prevalence of integrons and Antimicrobial Resistance Genes Among Clinical Isolates of Enterobacter spp. From Hospitals of Tehran vol.3, pp.1, 2011, https://doi.org/10.17795/ijep22531
  2. Association between the Presence of Aminoglycoside-Modifying Enzymes and In Vitro Activity of Gentamicin, Tobramycin, Amikacin, and Plazomicin against Klebsiella pneumoniae Carbapenemase- and Extended vol.60, pp.9, 2011, https://doi.org/10.1128/aac.00869-16
  3. Prevalence of Aminoglycoside Resistance Genes and Molecular Characterization of a Novel Gene, aac(3)-IIg, among Clinical Isolates of the Enterobacter cloacae Complex from a Chinese Teaching Hospital vol.64, pp.9, 2011, https://doi.org/10.1128/aac.00852-20
  4. WGS-Based Analysis of Carbapenem-Resistant Acinetobacter baumannii in Vietnam and Molecular Characterization of Antimicrobial Determinants and MLST in Southeast Asia vol.10, pp.5, 2011, https://doi.org/10.3390/antibiotics10050563